VanEck Associates
NGVT icon

VanEck Associates’s Ingevity NGVT Stock Holding History

VanEck Associates’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-695
Closed -$56K – 832
2018
Q2 		$56K Hold
695
– – ﹤0.01% 782
2018
Q1 		$51K Buy
695
+22
+3% +$1.65K ﹤0.01% 689
2017
Q4 		$47K Sell
673
-328
-33% -$23.7K ﹤0.01% 702
2017
Q3 		$63K Sell
1,001
-48
-5% -$2.84K ﹤0.01% 671
2017
Q2 		$60K Buy
1,049
+110
+12% +$6.47K ﹤0.01% 659
2017
Q1 		$57K Buy
939
+315
+50% +$17.8K ﹤0.01% 831
2016
Q4 		$34K Sell
624
-177
-22% -$8.49K ﹤0.01% 796
2016
Q3 		$37K Sell
801
-186
-19% -$7.85K ﹤0.01% 823
2016
Q2 		$34K Buy
+987
New +$30.8K ﹤0.01% 784

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VanEck Associates's NGVT Position: Q3 2018 in Review

VanEck Associates sold out of Ingevity (NGVT) in Q3 2018, closing a stake of 695 shares — an estimated $56K sold.

VanEck Associates first reported a position in NGVT in Q2 2016 and held it in 9 quarters. The position peaked at $63K in Q3 2017. 328 funds tracked by Wall St. Rank hold NGVT as of Q3 2018.

  • VanEck Associates reported no remaining Ingevity position as of Q3 2018 after selling out during the quarter.
  • VanEck Associates sold 695 Ingevity shares in Q3 2018, an estimated $56K.
  • VanEck Associates first reported a position in Ingevity in Q2 2016 and held it in 9 quarters.
  • VanEck Associates's Ingevity position peaked at $63K in Q3 2017.
  • 328 funds tracked by Wall St. Rank held Ingevity as of Q3 2018.

Based on VanEck Associates's 13F filing for Q3 2018, filed 13 Nov 2018.